ARCHIVES

Amgen Cancels Rilotumumab Trials in Gastric Cancer

This article is from The Cancer Letter archive.

Vol. 37 No. 12 | December 26, 2014

Download PDF Visit The Full Archive

Related Articles

Professional Issues: AMA Identifies Tobacco-Free Mutual Funds

February 21, 1997

DCPC Advisors Consider Asking DRG For Section On Prevention & Control

May 14, 1993

Schmidt Says He Erred In Remarks About Pauling’s Grant Applications

March 23, 1979

AHRQ Draft Report Finds No Benefit For Biomarker Testing In Oncology

February 5, 2010

In Brief: Let Salaries Rise To Legal Levels, Biomedical Panel Says; Prostatic Cancer Blood Test Found

July 9, 1976

Breast Cancer Progress Report Summaries

November 14, 1975